EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Substantial decrease of PFAS with anion exchange resin treatment – A clinical cross-over trial

Janne Julie Møller, Ann Christine Lyngberg, Paula Edeusa Christina Hammer, Esben Meulengracht Flachs, Ole Steen Mortensen, Tina Kold Jensen, Gesche Jürgens, Axel Andersson, Anne Merete Boas Soja, Morten Lindhardt

Environment International · 2024-03 · 185 · 108497

DOI: 10.1016/j.envint.2024.108497 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Environment International, 2024-03. Verfasst von Janne Julie Møller und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational and Social Medicine, University Hospital of Holbaek, Denmark. Hauptthemen laut MEDLINE: Environmental Pollutants, Alkanesulfonic Acids, Fluorocarbons. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) are heat and stain resisting chemicals. They are persistent, bioaccumulating and spread ubiquitously. Many hotspots where humans are exposed to high levels of PFAS have been reported. A few small observational studies in humans suggest that treatment with an Anion Exchange Resin (AER) decreases serum PFAS. This first clinical controlled crossover study aimed to assess whether AER decreases perfluorooctanesulfonic acid (PFOS) in highly exposed adults. METHODS: An open label 1:1 randomized treatment sequence crossover study with allocation to oral AER (cholestyramine 4 g three times daily) or observation for 12 weeks was conducted among citizens from a PFAS hotspot. Main inclusion criteria was serum PFOS > 21 ng/mL. Primary endpoint was change in serum PFOS levels between treatment and observational period. RESULTS: In total, 45 participants were included with a mean age of 50 years (SD 13). Serum PFOS baseline median was 191 ng/mL (IQR: 129-229) and decreased with a mean of 115 ng/mL (95 % CI: 89-140) on treatment, and 4.3 ng/mL in observation period corresponding to a decrease of 60 % (95 % CI: 53-67; p < 0.0001). PFHxS, PFOA, PFNA and PFDA decreased during treatment between 15 and 44 %. No serious adverse events were reported. CONCLUSIONS: Oral treatment with AER significantly lowered serum PFOS concentrations suggesting a possible treatment for enhancing elimination of PFOS in highly exposed adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Environmental PollutantsAlkanesulfonic AcidsFluorocarbonsAdultHumansMiddle AgedCross-Over StudiesAnion Exchange Resins

Stichwörter der Autor:innen

Anion exchange resinClinical trialEnvironmental chemistryPFASPharmacologycal treatment

Substanzen

Environmental PollutantsAnion Exchange Resinsperfluorooctane sulfonic acidAlkanesulfonic AcidsFluorocarbons

Autor:innen und Institutionen

  • Department of Occupational and Social Medicine, University Hospital of Holbaek, Denmark.
  • Department of Occupational and Social Medicine, University Hospital of Holbaek, Denmark; Department of Public Health, Section of Social Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, The Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark.
  • School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Internal Medicine 1, University Hospital - Holbaek, Holbaek, Denmark; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Förderung

  • Region Zealand

Zitieren

APA

Møller, J. J., Lyngberg, A. C., Hammer, P. E. C., Flachs, E. M., Mortensen, O. S., Jensen, T. K., Jürgens, G., Andersson, A., Soja, A. M. B., & Lindhardt, M. (2024). Substantial decrease of PFAS with anion exchange resin treatment – A clinical cross-over trial. Environment International, 185, 108497. https://doi.org/10.1016/j.envint.2024.108497

Vancouver

Møller JJ, Lyngberg AC, Hammer PEC, Flachs EM, Mortensen OS, Jensen TK, et al. Substantial decrease of PFAS with anion exchange resin treatment – A clinical cross-over trial. Environment International. 2024;185:108497. doi:10.1016/j.envint.2024.108497

BibTeX
@article{Mller2024,
  author = {Møller, Janne Julie and Lyngberg, Ann Christine and Hammer, Paula Edeusa Christina and Flachs, Esben Meulengracht and Mortensen, Ole Steen and Jensen, Tina Kold and Jürgens, Gesche and Andersson, Axel and Soja, Anne Merete Boas and Lindhardt, Morten},
  title = {Substantial decrease of PFAS with anion exchange resin treatment – A clinical cross-over trial},
  journal = {Environment International},
  year = {2024},
  volume = {185},
  pages = {108497},
  doi = {10.1016/j.envint.2024.108497}
}
Kostenlos starten →